Related Experiment Videos
[Autoantibodies against the Golgi apparatus]
G Renier1, F Carrère, A Chevailler
1Laboratoire d'immunopathologie, CHU, Angers, France.
La Revue De Medecine Interne
|March 1, 1994
Summary
Anti-Golgi autoantibodies, detected via immunofluorescence, are linked to autoimmune diseases like Sjögren's syndrome and lupus. Further research aims to identify specific autoantigens and patient subsets.
Area of Science:
- Immunology
- Autoimmunity
- Cell Biology
Context:
- Anti-Golgi autoantibodies were first identified a decade ago.
- Detection is commonly performed using immunofluorescence, with immunoblotting and immunoelectron microscopy offering insights into autoantigens.
- Distinguishing between low-titer antibodies (viral infections, healthy individuals) and high-titer antibodies (autoimmune diseases) is clinically relevant.
Purpose:
- To characterize anti-Golgi autoantibodies and their associated autoantigens.
- To explore the clinical significance of anti-Golgi autoantibodies, particularly in autoimmune conditions.
- To investigate the molecular weight and cellular localization of recognized autoantigens.
Summary:
- Anti-Golgi autoantibodies are typically polyclonal, often IgG isotype, and recognize molecules on Golgi cisternae membranes.
- High-titer antibodies are associated with autoimmune diseases such as Sjögren's syndrome and systemic lupus erythematosus, sometimes with liver dysfunction.
- Immunoblotting has revealed potential autoantigen molecular weights of 230, 150, and 79 kDa.
Impact:
- Contributes to understanding the pathogenesis of autoimmune diseases.
- May aid in identifying specific patient subsets associated with anti-Golgi autoantibodies.
- Highlights the need for further research into the nature and implications of these autoantibodies.